FDA Contract Awards In Brief: Regenerative Medicine, eCTD, Reg Science
Executive Summary
Contracts US agency awarded as fiscal year 2017 came to a close include one to Nexight for a regenerative medicine standards development process, another to Lorenz to manage eCTD submissions – and 26 more for regulatory science R&D.
You may also be interested in...
US FDA Pressing Industry To Use Standards For Cell and Gene Therapies
A US FDA official is exhorting the biopharmaceutical industry to adopt standards to help in developing new cell and gene therapy products, yet this may pose difficulties as there is a lack of standards in this space, particularly in areas such as cell viability, chain of identity and viral vector gene quantification.
Group Working To Close 'Standards Gaps' For Cell And Gene Therapies
A group is coordinating the development of standards for cell and gene therapies in a congressionally mandated effort that could help manufacturers produce these therapies at commercial scale.
FDA Expands Opioid Abuse Research, Outreach
US agency signs contracts for more real-world data on abuse; officials also meet with AMA representatives to discuss opioid prescriber education.